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Chronic exposure to drugs of abuse or stress regulates transcription factors, chromatin modifying 
enzymes, and histone posttranslational modifications in discrete brain regions. Due to the 
promiscuity of the enzymes involved, it has not yet been possible to obtain direct causal evidence 
to implicate the regulation of transcription and consequent behavioral plasticity by chromatin 
remodeling that occurs at a single gene. Here, we investigate the mechanism linking chromatin 
dynamics to neurobiological phenomena by applying engineered transcription factors to 
selectively modify chromatin at a specific gene in vivo. We found that histone methylation or 
acetylation at the FosB locus in nucleus accumbens—a brain reward region—is sufficient to 
control drug- and stress-evoked transcriptional and behavioral responses via interactions with the 
endogenous transcriptional machinery. This approach allows us to relate the epigenetic landscape 
at a given gene directly to regulation of its expression and to its subsequent effects on reward 
behavior.
Introduction
Drug addiction and depression are associated with altered expression or activity of particular 
transcription factors and histone-modifying enzymes, in both rodent models and human 
patients; experimental manipulation of such molecules in discrete brain regions alters the 
cellular and behavioral responses to drug or stress exposures in animals1-4. Studies of the 
mechanisms underlying altered gene expression in response to drugs or stress have involved 
analyses of transcription factor binding and enrichment of modified histones throughout the 
genome5,6. Interestingly, despite global enrichment in histone acetylation and depletion in 
histone methylation within a given brain region, many genes show alterations opposite to 
these, posing a key question as to the mechanism and relevance of gene-specific chromatin 
remodeling in the context of drug- and stress-evoked epigenetic changes. While work to date 
has laid the foundation for investigating the role of such histone modifications in regulating 
drug or stress responses, previous approaches have lacked the specificity needed to 
demonstrate the causal mechanisms by which a given chromatin modification at a specific 
gene is necessary and sufficient to regulate drug- or stress-evoked transcriptional and 
behavioral plasticity.
To overcome this limitation, we focused on the transcription factor, ΔFosB, which plays 
important roles, acting in the nucleus accumbens (NAc)—a key brain reward region, in drug 
and stress action7,8. ΔFosB is induced in the NAc by chronic cocaine exposure in rodents 
and in human cocaine addicts4,9, but is reduced by certain forms of chronic stress in rodents 
and in depressed humans10,11. The histone methyltransferase, G9a (EHMT2), which 
catalyzes dimethylation of histone H3 lysine 9 (H3K9me2), a repressive histone 
modification12, appears to be crucial in mediating this regulation: H3K9me2 enrichment at 
FosB is suppressed in the NAc by repeated cocaine12 and we show here that it is increased 
at FosB in the NAc of depressed humans. Moreover, we have demonstrated that local 
overexpression or knockdown of G9a in NAc potently controls drug and stress responses in 
rodent11,12. Nevertheless, this quality of proof is inherently limited because drugs and stress, 
as well as G9a manipulations, affect H3K9me2 enrichment at hundreds of loci in this brain 
region1,12,13. These previous studies underscore the fact that all current evidence for the 
epigenetic basis of reward pathology has relied on correlating the effects of global 
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manipulations of histone posttranslational modifications (HPTMs) with affected behavior 
and physiology, resulting in a limited analysis of the transcriptional mechanisms linking 
epigenetic modifications at a single gene to the transcriptional activity of that gene and 
subsequent reward behavior.
Here, we sought to achieve a stronger level of proof by use of engineered transcription 
factors, zinc-finger proteins (ZFPs)14 or transcription activator-like effectors (TALEs)15, 
that can be designed in silico to recognize and bind to a specific 18 to 20-bp locus in the 
genome. Fusion of the DNA-binding domain to a given catalytic domain allows gene-
targeted transcriptional regulation at a site of interest. ZFPs and TALEs have been applied in 
vitro and shown to efficiently activate or repress gene expression when fused to any of 
several functional domains. More recently, ZFPs and TALEs have been used in vitro to 
promote epigenetic remodeling when fused to chromatin modifying enzymes14,16,17. 
Although very few studies to date have utilized this approach in vivo, one study showed 
reversal of a Parkinsonian phenotype in a mouse model by overexpression of a ZFP-
transcriptional activator directed against the promoter of glial cell line-derived neurotrophic 
factor (Gdnf), which conferred protection from a striatal chemical lesion18. We thus took 
advantage of this novel approach to investigate the causal role of cocaine- and stress-evoked 
epigenetic regulation of the FosB locus in the NAc in vivo.
Results
Generation of ZFPs that target the FosB gene in vivo
To direct locus-specific epigenetic changes to a specific gene we screened a suite of cys2-
his2 six-finger ZFPs19 for regulation of FosB transcription, designed in silico to span the 
murine FosB promoter at various 18-20 bp motifs within –1000 to +200 bp relative to the 
transcription start site (TSS) (Fig. 1a, c). As an initial proof of principle, each ZFP was fused 
to the p65 domain of the mammalian transcription factor NFkB, which activates 
transcription by promoting histone acetylation via recruitment of p300/CBP (CREB binding 
protein)20. Histone acetylation has been shown to modulate drug- and stress-evoked 
behavior21-23 and gene expression1,24, in part by regulating drug-associated memory 
formation25,26. A subset of the FosB-ZFP-p65 constructs were transfected into Neuro2a 
(N2a) cells and their relative efficacy was determined by qRTPCR analysis of FosB/ΔFosB 
mRNA expression (Supplementary Fig. 1). ZFP25, -35, and -61 were selected as potent 
activators of FosB transcription and subjected to further analysis. To study regulation of the 
FosB gene in vivo, we injected mouse NAc (Fig. 1b and Supplementary Fig. 2a) with herpes 
simplex virus (HSV) vectors expressing various FosB-ZFP-p65 or -NFD (no functional 
domain) constructs and quantified FosB/ΔFosB mRNA using qRT-PCR.
We found that HSV-FosB-ZFP35 and –ZFP65-p65 constructs activated transcription of 
FosB/ΔFosB in the NAc relative to HSV-GFP or -NFDs (Fig. 1d). To address the 
mechanism of the repressive histone mark H3K9me2 in regulation of FosB expression, we 
generated FosB-ZFP-G9a constructs, in which each of three distinct ZFPs was fused to the 
minimal catalytic domain of G9a14,27. HSV delivery of FosB-ZFP35-G9a and -ZFP61-G9a 
to the NAc efficiently repressed FosB/ΔFosB mRNA expression (Fig. 1d). The changes in 
the amount of FosB/ΔFosB mRNA we observed in the NAc are physiologically relevant, 
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and similar in magnitude to drug- and stress-induced changes observed previously1,24. In 
addition to regulation of basal mRNA expression, we found by immunoblotting that FosB/
ΔFosB protein is elevated in NAc expressing HSV-FosB-ZFP35-p65 (Fig. 1e), while there is 
no effect in NAc infected with HSV-FosB-ZFP35-G9a, relative to the -NFD at 72 hours post 
infection. To more carefully examine FosB repression by HSV-FosB-ZFP35-G9a, we 
performed immunohistochemistry and found that the percentage of FosB/ΔFosB 
immunopositive cells decreased dramatically as a percentage of HSV infected (GFP+) cells 
in NAc infected with HSV-FosB-ZFP35-G9a compared to a control vector (Supplementary 
Fig. 2b). These findings confirm that the ZFPs exert their function within the HSV-infected 
neurons that express FosB/ΔFosB.
The ability to site-specifically regulate chromatin architecture enables direct examination of 
the function of HPTMs in regulating gene transcription in the brain. We used semi-
quantitative chromatin immunoprecipitation (qChIP) and found enrichment of the activating 
histone modification, H3K9/K14 acetylation, at the FosB promoter (Fig. 1f) in NAc infected 
with HSV-FosB-ZFP35-p65 - an effect that was not observed in NAc infected with HSV-
FosB-ZFP35-G9a (Fig. 2a). Conversely, NAc infection with HSV-FosB-ZFP35-G9a led to 
enrichment of the repressive histone modification, H3K9me2, at the FosB promoter (Fig. 
1g). Importantly, neither HPTM was enriched at the promoter of the related immediate early 
gene, cFos (Fig. 1f, 1g), nor was H3K9me2 enriched globally in total NAc extracts 
[H3K9me2: t(1, 15)=1.35, p=0.20, n=8 NFD, n=9 G9a]. Taken together, these results 
demonstrate that viral expression of engineered ZFPs efficiently enrich their respective 
HPTMs at the FosB promoter and bi-directionally control FosB gene expression in vivo.
The analysis of control constructs was critical to our investigation, as both a ZFP with no 
functional domain (NFD)28 or the functional domain alone29 may have nonspecific effects 
on transcription. We found that neither the p65 nor G9a domains alone regulated expression 
of FosB when virally expressed in the NAc (Fig. 1d). Furthermore, ZFPs targeted to 
unrelated genes, Klf4-ZFP-p65 and VEGF-ZFP-G9a, did not affect FosB/ΔFosB expression 
in the NAc (Fig. 1d). Finally, NAc expression of HSV-FosB-ZFP35-NFD had no effect on 
FosB/ΔFosB mRNA levels (Fig. 1d), or on enrichment of HPTMs at the FosB promoter 
(Fig. 1f, g). We did find that FosB-ZFP61-NFD repressed FosB expression (Fig. 1d), 
perhaps because its binding site is just downstream from the TSS (see Fig. 1a), and thus 
excluded this ZFP from further study.
To determine specificity of FosB gene regulation by FosB-ZFP35, we examined the mouse 
genome for 19 bp motifs that differed from the ZFP35 binding motif by 1-, 2- or 3-
nucleotides and were located within 3 kb of a transcription start site (no site shared the 
identical 19 bp sequence; Supplementary Table 2). We found by qRT-PCR that the 
expression of these 28 off-target genes was unaffected by NAc expression of HSV-FosB-
ZFP35-p65, -G9a or -NFD (22 genes) or was undetectable (6 genes) (Fig. 2b). Finally, we 
selected those loci located within 1000 bp upstream of their respective TSSs and found that 
HSV-FosB-ZFP35-G9a in NAc did not alter H3K9me2 binding at any of these 6 off-target 
sites (Fig. 2c). This detailed analysis of specificity goes further than previous publications to 
assess the off-target regulation by ZFPs in vivo. Nonetheless, we cannot rule out the 
possibility of undetected off-target regulation of additional genes that may contribute to the 
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transcriptional and behavioral changes induced by FosB-ZFP35-G9a or -p65. Based on this 
detailed characterization, we focused on FosB-ZFP35 for the remainder of the experiments 
in this study.
Mechanisms of action of FosB-ZFP-G9a in NAc
To investigate the potential mechanism by which FosB promoter enrichment of H3K9me2 
regulates expression of FosB/ΔFosB, we examined additional histone modifications and 
histone binding proteins, which may contribute to gene repression. We found that expression 
of HSV-FosB-ZFP-G9a in NAc did not alter enrichment of tri-methylated histone H3 lysine 
27 (H3K27me3) or histone H3 lysine 4 (H3K4me3), known repressive and activating marks, 
respectively, at the FosB gene (Fig. 2). We next examined two marks that have been 
strongly implicated in repression, acting in concert with H3K9me2,, tri-methylated histone 
H3 lysine 9 (H3K9me3) and heterochromatin protein 1α (HP1α)30,31. We found that HSV-
FosB-ZFP-G9a in NAc decreased levels of H3K9me3, but induced a ~2-fold enrichment of 
HP1α, at the FosB promoter compared to HSV-FosB-ZFP-NFD (Fig. 1h). However, the 
level of H3K9me3 and HP1α binding to FosB is nearly an order of magnitude below that of 
H3K9me2, raising the possibility that other factors are primarily involved in mediating FosB 
repression associated with increased H3K9me2 at euchromatic regions in adult brain. 
Interestingly, both H3K9me3 depletion and HP1α enrichment were detected only at a site 
-1200 bp upstream from the FosB TSS, which we found to be the major site of enrichment 
of H3K9me2 in response to HSV-FosB-ZFP35-G9a (Fig. 1g) and under physiological 
conditions in both mouse12,13 and human (Fig. 3g) NAc. This site is ~1000 bp upstream of 
the ZFP35 binding site (see Fig. 1a), suggesting that the binding of G9a to a proximal site on 
the FosB promoter induces a spreading repressive mechanism that affects a relatively large 
span of the FosB gene. Based on these findings, we further investigated an additional 
epigenetic signature, DNA methylation. While we observed methylation of the 3 predicted 
CpG sites within this -1200 bp region of FosB by bisulfite conversion, there was no effect of 
HSV-FosB-ZFP35-G9a (Fig. 1i). Importantly, the site targeted by ZFP35 coincides with a 
region where we have demonstrated regulation of endogenous G9a binding in response to 
cocaine treatments12, supporting the physiological relevance of FosB-ZFP35-G9a action in 
regulating FosB expression, and the potential use of this tool for understanding mechanisms 
controlling FosB expression in vivo.
Given that cocaine-induced ΔFosB protein accumulation critically contributes to the 
addiction phenotype, we sought to interfere with this physiological response by inducing 
H3K9me2 specifically at the FosB locus. Mice were injected with HSV-FosB-ZFP35-G9a 
and - NFD into the right and left NAc, respectively, and then treated with repeated saline or 
cocaine (20 mg/kg) over a time course designed to coincide with HSV-expression (72 hours) 
while still sufficiently long enough to lead to FosB/ΔFosB protein accumulation in NAc 
(Fig. 3a). Immunohistochemical analysis using an anti-FosB/ΔFosB antibody demonstrated 
that, while cocaine increased the number of FosB immunopositive NAc neurons by 39% in 
NAc infected with control virus, expression of HSV-FosB-ZFP35-G9a blocked this 
induction (Fig. 3b, c). At this time point (7 days after HSV injection) HSV-mediated 
transgene expression has fully dissipated, thus, it is not possible to selectively examine the 
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infected cells, which likely accounts for the fact that expression of FosB/ΔFosB in saline-
treated animals was not affected by HSV-FosB-ZFP35-G9a (Fig. 3b, c).
To further our understanding of cocaine-regulated FosB expression, we sought to discover a 
molecular mechanism by which an increase in H3K9me2 solely at the FosB promoter blocks 
cocaine induction of FosB/ΔFosB protein in vivo. We reasoned that this repressive histone 
modification might interfere with activation (i.e., phosphorylation) of cAMP response 
element binding protein (phospho-CREB[S133]) and/or serum response factor (phospho-
SRF[S103]), both of which are required for FosB induction in the NAc by repeated 
cocaine32. We injected mouse NAc with either control HSV or HSV-FosB-ZFP35-G9a, and 
then treated the animals with either repeated saline or cocaine (20 mg/kg). qChIP revealed 
that cocaine treatment results in a 3.9-fold enrichment of phospho-CREB at the FosB 
promoter compared to saline treated mice (Fig. 3d). This enrichment was blocked by NAc 
injection of HSV-FosB-ZFP35-G9a (Fig. 3d). As previously demonstrated32, cocaine had no 
significant effect on the enrichment of total CREB protein at the FosB promoter, nor did 
HSV-FosB-ZFP35-G9a alter levels of total CREB binding (Fig. 3e). Interestingly, cocaine 
treatment also caused enrichment of phospho-SRF binding at the FosB promoter, but there 
was only a modest effect of HSV-FosB-ZFP35-G9a (Fig. 3f), despite the close proximity of 
the CREB and SRF binding sites (see Fig. 1a). We also examined the enrichment of HP1α at 
the FosB promoter and found that while cocaine does not regulate binding of this protein to 
FosB in NAc, HSV-FosB-ZFP35-G9a expression leads to enrichment of HP1α in either the 
cocaine or saline context (Fig. 3g), as shown earlier (Fig. 1h). These data demonstrate that, 
in fully differentiated adult neurons in vivo, a primary increase in H3K9me2 at a given gene 
controls enrichment of an activated transcription factor at that gene, and the gene's 
expression, in response to an environmental stimulus.
Regulation of FosB by transcription activator-like effectors—To gain a broader 
understanding of transcriptional regulation by engineered transcription factors, we targeted 
the FosB gene with transcription activator-like effectors (TALEs)17,33, a distinct type of 
designer DNA binding domain, as well as with a variety of transcriptional activators, 
including VP64, VP16, and 2xp65 (Supplementary Fig. 3). FosB-TALEs fused to the 
transactivator, VP64, efficiently upregulated expression of FosB/ΔFosB when virally 
expressed in the NAc, while Klf4-TALE-VP64 had no effect (Supplementary Fig. 3b). 
Furthermore, VP16, VP64, or 2xp65 activated FosB/ΔFosB expression when fused to FosB-
ZFP35 and expressed in N2a cells (Supplementary Fig. 3d).
Such a comprehensive analysis demonstrated that engineered transcription factors are 
potent, bidirectional regulators of FosB/ΔFosB expression, yet we also found that their 
effect in cell culture was not always an accurate predictor of their function in brain. For 
example, FosB-ZFP25-p65 robustly activated FosB/ΔFosB expression in N2a cells 
(Supplementary Fig. 1), but failed to activate transcription when expressed in NAc neurons 
in vivo (Fig. 1d). We also observed that several FosB-ZFP-G9a constructs activated FosB 
expression in N2a cells (Supplementary Fig. 1) but repressed expression in NAc neurons in 
vivo (Fig. 1d). To investigate a potential explanation for these discrepancies, we compared 
the expression level of ZFP constructs in vitro vs. in vivo and found several orders of 
magnitude greater expression in N2a cells than in NAc (Supplementary Fig. 4a). However, 
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titration of the amount of FosB-ZFP35-G9a expressed in N2a cells affected the expression 
of ΔFosB, but not FosB, mRNA, indicating that ZFP expression levels account only in part 
for its distinct function in vitro and in vivo (Supplementary Fig. 4b). An alternative 
explanation is provided by the fact that chromatin state is a major determinant of 
transcription binding and function and that such states differ between cell types34,35. These 
data underscore the importance of our approach in using an in vivo system to characterize 
engineered transcription factors as tools to study epigenetic mechanisms of gene regulation 
in reward regions of mammalian brain.
Regulation of reward behavior by FosB-ZFPs
Having established a mechanism whereby engineered transcription factors can specifically 
regulate ΔFosB expression in vivo, we next investigated their ability to modulate reward 
behaviors, studying first the regulation of cocaine action. Animals were injected intra-NAc 
with HSV-FosB-ZFP35, -TALE1, or control vectors and their locomotor activity was 
recorded over several days of cocaine treatment at either a sensitizing dose (10 mg/kg) or a 
subthreshold dose (5 mg/kg) that does not lead to locomotor sensitization in control animals 
(Fig. 4a, Supplementary Fig. 3e). We found that HSV-FosB-ZFP35-G9a expression in NAc 
efficiently blocked cocaine locomotor sensitization (10 mg/kg) (Fig. 3c), while both HSV-
FosB-ZFP35-p65 and HSV-TALE1-VP64 augmented the sensitizing effects of the drug, 
with no effect of HSV-FosB-ZFP35-NFD (5 mg/kg) (Fig. 4d, e and Supplementary Fig. 3e). 
None of the constructs affected baseline locomotor activity seen in the absence of cocaine 
compared to control virus (Fig. 4c-e and Supplementary Fig. 3e).
Recent evidence has also implicated a reduction of ΔFosB levels in the NAc in the etiology 
of depression in humans and in chronic stress models in rodents8. Indeed, we found that 
depressed human NAc exhibited a 37% enrichment of H3K9me2 at the FosB promoter (Fig. 
3g), specifically at a site 1200 bp upstream from the TSS, coincident with the site of greatest 
H3K9me2 enrichment at the FosB promoter in mouse NAc (Fig. 1g). Based on these results, 
we examined the effect of artificially inducing H3K9me2 selectively at the FosB gene in 
mouse NAc, thus mimicking this single pathological histone modification in depressed 
humans. We relied on a variant of the chronic social defeat stress (CSDS) paradigm, in 
which animals are subjected to a subthreshold social stress that has no effect on depression-
related behaviors, such as social avoidance, in normal animals36. Mice were injected with 
HSV-FosB-ZFP-G9a into NAc, allowed to recover for five days, and then exposed to an 
aggressor for three bouts of five minutes each (Fig. 4b). In contrast to control virus, mice 
that were infected with HSV-FosB-ZFP35-G9a showed reduced social interaction when 
tested 24 hours after the aggressive encounter, a pro-depression-like behavioral response 
(Fig. 4i). Further, we found that these mice spent significantly less time exploring the open 
arms in the elevated plus maze, indicative of increased anxiety-related behavior (Figure 3h). 
Thus, mimicking a single HPTM abnormality seen at a single gene in the NAc of depressed 
humans is sufficient to promote behavioral susceptibility to stress.
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Discussion
In the current study, we used engineered transcription factors to site-selectively remodel 
chromatin in a discrete brain region to control both the molecular and behavioral effects of 
drug- and stress-exposure. We targeted the FosB gene because of its known role in the 
pathophysiology of drug addiction and depression in both rodents and humans, which has 
been linked to epigenetic remodeling at this locus. Specifically, drug-induced activation of 
FosB is correlated with increased histone acetylation and decreased histone methylation at 
its promoter, yet it has not previously been possible to elucidate the functional relevance of 
such changes due to the genome-wide context within which they occur. To overcome this 
limitation, we designed a suite of engineered transcription factors that target the FosB locus 
and applied them to the expression of FosB/ΔFosB under both basal and cocaine-induced 
conditions. We found that FosB-ZFPs and -TALEs fused to the transcriptional activators, 
p65 or VP64, respectively, activate FosB/ΔFosB expression both in cultured cells and when 
virally expressed in NAc. NAc expression of FosB-ZFP35-p65 induces histone acetylation 
across the FosB promoter, a modification previously implicated in cocaine-induced 
activation of this locus1. We show here that acetylation of FosB by FosB-ZFP35-p65 is 
sufficient to enhance the sensitizing effects of cocaine, indicating that ZFP-induced 
acetylation may act synergistically with cocaine-activation of this gene to produce an 
enhanced behavioral response. In a complementary paradigm, we found that histone 
methylation by FosB-ZFP35-G9a is sufficient to repress basal expression of FosB/ΔFosB in 
vivo and block cocaine locomotor sensitization. These results represent the first 
demonstration of ZFP-induced chromatin modifications in vivo, and the first use of 
engineered transcription factors to elucidate transcriptional dysregulation underlying 
neuropsychiatric disease.
Importantly, we included numerous control constructs in our study to rule out the effects of 
stoichiometric interference by ZFPs in the transcription of FosB. We found that FosB-
ZFP35 without a functional domain did not affect FosB/ΔFosB expression or chromatin 
modification, in either the basal or cocaine contexts. To further establish the specificity of 
our engineered transcription factors in targeting FosB selectively, we analyzed the 
regulation of 28 potential off-target binding motifs in vivo, each of which differs from the 
ZFP35 binding site by 1 to 3 nucleotides, and found no transcriptional regulation of their 
associated genes by FosB-ZFP35-p65 or -G9a. In addition, we found no enrichment of 
H3K9me2 at 6 of these sites examined after expression of FosB-ZFP35-G9a. Our results are 
in accordance with a still small number of in vitro studies that have examined ZFP or TALE 
specificity, and concluded that there is little to no genome-wide transcription regulation by 
gene-targeted engineered transcription factors17,37,38. Our data are the first to demonstrate 
the functional specificity of engineered transcription factors in neurons in vivo, thus greatly 
enhancing their application to the study of the epigenetic underpinnings of neuropsychiatric 
disease.
Previous studies have demonstrated the dynamic regulation of histone methylation by both 
chronic cocaine and stress11,12. In particular, repeated cocaine reduces G9a expression and 
the enrichment of H3K9me2 in the NAc, resulting in derepression at hundreds of genes, 
including FosB; viral overexpression of G9a in NAc increases H3K9me2 at FosB, represses 
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ΔFosB expression, and inhibits cocaine reward behavior12. Our results improve upon this 
previous approach by targeting G9a specifically to the FosB gene, thereby arguing against 
effects of G9a across the genome, and directly implicating G9a-induced H3K9me2 at FosB 
in the specific mechanism of FosB gene repression.
Histone methylation is thought to repress gene expression via the recruitment of additional 
methyltransferases and HP1, which can lead to the formation of silent heterochromatin30,39. 
We found that FosB-ZFP35-G9a induces H3K9me2 enrichment across the FosB promoter, 
up to 1000 bp upstream from the ZFP recognition motif. This site, 1250 bp upstream from 
the FosB TSS, shows the greatest basal enrichment in H3K9me2 in both mouse and human 
NAc, and we found that following ZFP-induced H3K9me2, binding of HP1α is increased 
only at this location. In non-nervous tissues, repression by H3K9me2 often involves not only 
the recruitment of HP1 but also generation of H3K9me3 and can spread to adjacent genomic 
regions40,41. Given the widespread methylation induced by FosB-ZFP35-G9a, we 
investigated H3K9me3 binding across the FosB promoter and found, surprisingly, that this 
modification was depleted at the site of HP1α and H3K9me2 co-enrichment, with no 
regulation elsewhere in the FosB promoter. We also measured DNA methylation at three 
CpGs located adjacent to this region, as DNA methyltransferase is also often recruited by 
HP1 and H3K9me2/342, but did not find regulated DNA methylation regulation coincident 
with induced H3K9me2. Taken together, our results demonstrate a causal mechanism of 
gene repression at a euchromatic locus that is initiated by G9a recruitment, leading to 
enrichment of H3K9me2 and binding of HP1α, a mechanism of G9a/H3K9me2 action 
within fully differentiated adult neurons in vivo that differs from models based on other 
systems.
We next investigated a potential mechanism by which ZFP-induced H3K9me2 enrichment 
blocked cocaine-evoked FosB expression in NAc. We found that this manipulation was 
sufficient to prevent the increase in phospho-CREB at the FosB promoter, which is required 
for cocaine-evoked FosB/ΔFosB expression32 and known to be important for cellular and 
behavioral plasticity relevant to drug exposure8. Our results show no effect of H3K9me2 on 
the binding of total CREB or of phospho-SRF, indicating a specific action of H3K9me2 in 
preventing the phosphorylation of CREB already bound to FosB. These results thus provide 
the first direct evidence by which a drug-evoked histone modification regulates gene 
expression by controlling transcription factor activity. Further studies will be needed to shed 
light on the mechanism by which H3K9me2 enrichment prevents CREB phosphorylation, 
especially given the ~1000 bp distance between their binding sites.
FosB has also been implicated in the cellular and behavioral correlates of stress and 
depression. In particular, previous studies have demonstrated that FosB/ΔFosB expression in 
the NAc is deficient in the social isolation model of depression in mice and in this region of 
postmortem human depressed patients, and that increased FosB/ΔFosB expression in NAc 
protects animals from the deleterious effects of chronic stress8. To complement these data, 
we found that H3K9me2 is enriched at the FosB promoter in NAc of human depressed 
patients relative to controls, implicating this repressive epigenetic modification in the 
repression of FosB in this population. Indeed, we found that ZFP-induced enrichment of 
H3K9me2 at FosB in mouse NAc was not only sufficient to reduce FosB/ΔFosB expression, 
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it also induced a prodepressive state, as manifested by depression- and anxiety-like 
behaviors after social stress. These data thus suggest a causal epigenetic mechanism for 
FosB repression in the pathophysiology of depression.
In summary, we have demonstrated that histone methylation or acetylation per se at the 
FosB locus in the NAc is sufficient to dynamically regulate gene expression at this locus and 
thereby control the behavioral effects of cocaine or stress exposure. The ability to site-
specifically modify chromatin enabled us to model a pathological epigenetic marker of 
human addiction and depression and observe the effects on drug and stress susceptibility in 
mice. Our findings also suggest that a primary change in H3K9me2 is sufficient to drive 
downstream changes in transcription factor binding and gene expression, which is in 
contrast to current models of HPTMs occurring mostly secondarily to alterations in 
transcription factors. By expanding this novel approach to target additional genes and 
HPTMs regulated by emotional stimuli, it will be possible to gradually build a detailed 
understanding of the epigenetic basis of addiction and depression.
Methods
Animals and treatments
Male 7-8 week old C57BL/6J mice and 6-month old CD1 retired breeders (CD1 aggressor) 
were housed at 22-25°C in a 12-hr light/dark cycle and provided food and water ad libitum. 
Animals were housed five per cage and habituated in our facility for at least 1 week before 
experimentation and all tests were conducted during the light cycle. Members of the same 
cage were randomly assigned to different experimental groups for behavioral studies and the 
order of testing was distributed across groups. Wherever possible, the experimenter 
conducting the data analysis was blind to treatment conditions of the animals. All 
experiments were conducted in accordance with the guidelines of the Institutional Animal 
Care and Use Committee at Mount Sinai. Group size determination was based on published 
protocols for the behavioral paradigm in use; no statistical test was used to predetermine 
sample size. For repeated cocaine experiments (immunohistochemistry, chromatin 
immunoprecipitation [ChIP]), animals received daily injections of either saline (5 treatments 
saline, i.p.), or saline followed by cocaine (1 treatment saline, 4 treatments cocaine, 20 
mg/kg, i.p.) and sacrificed 24 hours after the last injection. Sample size was determined 
based on empirical data in preliminary experiments and published protocols.
Transcription factor engineering
All zinc finger proteins (ZFPs) were manufactured by the CompoZr ZFN Operations Group 
at Sigma-Aldrich Biotechnology and cloned in frame N-terminal to the activation or 
repression domain. The ZFPs recognize the following unique 18-20 bp motifs in the FosB 
promoter: ZFP1: TCCGTGACAAAGCTAGTGG; ZFP14: ACCTTCTCCAACCCGGGT; 
ZFP25: CAACAGCGGGCGCGCGCAG; ZFP29: CCAAACAAACACTGGGCCGC; 
ZFP31:GGCCGCGCTGGCCGAGCTCC; ZFP35: GATCCCCTCCCGCGAAGCC; ZFP54: 
TGCGGGTGACGCAAGCGCG; ZFP61: GCCGGGGACACGCGGAGCC and Klf4 
promoter: GTGACCCGCGCCCATGGCC. All transactivator-like effector (TALE) 
constructs were generated as described previously15. Briefly, TALE binding sites, 18-nt 
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targets with T as the first base, were selected from the promoter region of FosB. All TALE 
repeat arrays were constructed using modular assembly followed by insertion into cloning 
backbones containing the non-repetitive TALE capping regions and the VP64 transcription 
activator. The identities of repeat variable diresidues (RVDs) in each TALE repeat array are 
as follows (Name, Target Site (5’ to 3’), Repeat Array RVDs) or published33: FosB-TALE1, 
TCCCCTCCCGCGAAGCCC, HD-HD-HD-HD-NG-HD-HD-HD-NN-HD-NN-HI-HINN-
HD-HD-HD; FosB-TALE2, TCACCCGCAACTCCATGC, HD-NI-HD-HD-HD-NN-HD-
NI-NI-HD-NG-HD-HD-NI-NG-NN-HD; FosB-TALE3, TACGCCGGGGACACGCGG, NI-
HD-NN-HD-HD-NN-NN-NN-NN-NI-HD-NI-HD-NN-HD-NN-NN.
Bioinformatics
Bowtie was used to align FosB-ZFP35 motif to mouse genome (mm9)44, and three 
mismatches at maximum was allowed (parameter: -v 3). Then region_analysis.pl, a genome
N2a transfection and RNA isolation
Neuro2a cells (ATCC CCL-131; manufacturer's authentication available online) were 
cultured and transfected with 400 ng plasmid DNA using Effectene reagent (Qiagen) and 
RNA was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturers 
instructions. qPCR and data analysis were performed as described11, using the primers listed 
in Table S1. Data were analyzed by comparing C(t) values of the experimental construct 
with mock-transfected cells using the ΔΔC(t) method.
Viral-mediated gene transfer
Mice were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) 
and prepared for stereotaxic surgery. Thirty-three gauge syringe needles (Hamilton) were 
used to bilaterally infuse 0.5-1.0 ml of virus into NAc at a rate of 0.1 ml/min at 1.6 mm A/P, 
+1.5 mm lateral, and 4.4 mm D/V from Bregma. We used bicistronic p1005 HSV vectors 
expressing GFP alone or GFP plus FosB-ZFP or FosB-TALE. In this system, GFP 
expression is driven by a cytomegalovirus (CMV) promoter, whereas the select gene of 
interest is driven by the IE4/5 promoter12. As with other HSV vectors, we detected no 
change in neuronal viability with any of the vectors utilized in this study.
NAc RNA isolation and qRT-PCR
72 hours after viral infection, when transgene expression is maximal, mice were rapidly 
decapitated, and brains were removed and placed on ice. A fluorescence microscope (Leica) 
was used to visualize accurate NAc targeting of GFP-expressing virus and to accurately 
dissect only infected tissue. Dissections of NAc were taken with a 1 mm aluminum micro-
punch (Harris) and quickly frozen on dry ice until RNA was extracted. RNA isolation, 
qPCR, and data analysis were performed as described11, using the expressing virus and to 
accurately dissect only infected tissue. Dissections of NAc were taken with a 1 mm 
aluminum micro-punch (Harris) and quickly frozen on dry ice until RNA was extracted. 
RNA isolation, qPCR, and data analysis were performed as described11, using the primers 
listed in Table S2. Data were analyzed by comparing C(t) values of the experimental virus 
with control virus using the ΔΔC(t) method.
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Western blotting
Frozen NAc tissue was homogenized in 30 μl of RIPA buffer containing 10 mM Tris, 150 
mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 1% Sodium Deoxycholate, and 
protease inhibitors (Roche, Basel, Switzerland) using an ultrasonic processor (Cole Parmer, 
Vernon Hills, IL, USA). Protein concentrations were determined using a DC protein assay 
(Bio-Rad, Hercules, CA, USA), and 50 μg of protein were loaded onto 4-15% gradient Tris-
HCl polyacrylamide gels for electrophoresis fractionation (Bio-Rad). Proteins were 
transferred to nitrocellulose membranes, blocked with Odyssey® blocking buffer (Li-Cor, 
NE, USA), and incubated overnight at 4°C with primary antibodies (FosB/ΔFosB: Cell 
signalling 255112 H3K9me2: Abcam ab122012) in Odyssey® blocking buffer. After 
thorough washing with 1x Tris-Buffered Saline plus 0.1% Tween-20, membranes were 
incubated with IRDye® secondary antibodies (1/5000 to 1/10000; Li-Cor, Lincoln, NE, 
USA) dissolved in Odyssey® blocking buffer for 1 hr at room temperature. For analysis, the 
blots were imaged with the Odyssey® Infrared Imaging system (Li-Cor, Lincoln, NE, USA) 
and quantified by densitometry using ImageJ (NIH, Bethesda, Maryland, USA). The amount 
of protein blotted onto each lane was normalized to levels of actin (MP BioMedicals Clone 
C4). Representative image and data shown are from one experiment of two biological 
replicate experiments using two animal cohorts.
Immunohistochemistry, imaging and cell counting
Adult males were terminally anesthetized (chloral hydrate) and transcardially perfused with 
PBS followed by 4% paraformaldehyde. Brains were then post-fixed overnight in 4% 
paraformaldehyde at 4°C, cryoprotected in 30% sucrose at 4°C until isotonic, and stored at 
-80°C. 35 μm coronal sections were sliced on a freezing microtome. Striatal sections were 
washed in PBS and blocked with 3% normal donkey serum (NDS) before incubating in 
primary antibody (rabbit-anti-FosB, 1:1000, Santa Cruz Biotechnology sc-4846; rabbit-anti-
DARPP32, 1:1000, AbCam ab4080147; mouse-anti-NeuN, 1:10000, Millipore 
MAB37746,48; chicken-anti-GFP, 1/8000, Aves Labs GFP 10-1012) in 0.1% Triton-
X100/3%NDS/PBS at 4°C overnight. Sections were then washed in PBS, incubated in 
secondary antibody (Cy3 conjugated donkey-anti-rabbit, or -mouse, Cy2 conjugated goat 
anti-chicken, Jackson Immuno) in 0.1% Tween-20/PBS, washed, and mounted on poly-L-
lysine coated slides. Slides were washed briefly in 75% ethanol, dried, and coverslipped 
with ProLong Gold anti-fade with DAPI (Life Technologies). Slides were stored in a light-
proof box at 4°C before and after imaging. Slides were imaged on an Axio Observer 
Inverted Microscope (Zeiss) fitted with fluorescent filters. For each animal, 4-8 sections 
along the A-P axis of the NAc were imaged at 20x magnification (AxioVision imaging 
software, Zeiss) by an observer blind to conditions. For anatomical consistency, images 
included a portion of the anterior commissure as a marker of the NAc. Images were taken 
simultaneously for DAPI, GFP, and FosB (Cy3). Adjustments were made as necessary to 
accurately capture fluorescent intensity. Analysis of FosB+ cells was performed using 
ImageJ. Within the red channel, threshold was adjusted to accurately count moderate- to 
highly-expressing FosB+ cells. An elliptical of a constant size selected a region of interest 
through the core and shell of the NAc, and particles were analyzed (size: 15-175; circularity: 
0.01-1) for each image. Representative image and data shown are from one experiment of 
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two technical replicate experiments, in which sections from the same cohort of animals were 
subject to immunohistochemical analysis.
Chromatin immunoprecipitation
ChIP was performed on bilateral NAc 15-gauge punches pooled from 4-5 mice 72 hours 
after viral infection or 24 hours after the last drug treatment, and dissected as described 
above, or (2) 5 × 106 N2a cells 48 hours after transfection. Chromatin was prepared as 
described previously1, and sheared using a diogenode bioruptor XL at high sonication 
intensity for 30 sec on/ 30 sec off for either 2x25 minutes. Fragment size was verified with 
an Agilent 2100 bioanalyzer at 150-300 bp or 1000-3000 bp respectively. Sheared chromatin 
was incubated overnight with the following antibodies previously bound to magnetic beads 
(Dynabeads M-280, Life Technologies): anti-H3K9me2 antibody (AbCam ab122012), anti-
H3K27me3 (AbCam ab60025), anti-H3K4me3 (EMD Millipore 17-6145), H3K9/14ac 
(EMD Millipore 17-6151), anti-H3K9me3 (EMD Millipore 07-44249), anti-HP1α (EMD 
Millipore 05-68950), anti-CREB (EMD Millipore 17-60032), anti-phospho-CREB (EMD 
Millipore 17-1013132), anti-phospho-SRF (AbCam ab53130). After reverse cross-linking 
and DNA purification (Qiagen Spin Column), binding to the FosB promoter was determined 
by qRT-PCR using the primers listed in Table S2.
DNA methylation
NAc tissue from three each of HSV-FosB-ZFP35-NFD and HSV-FosB-ZFP35-G9a viral 
injected animals was collected at Day 4 after surgery. Genomic DNA was isolated following 
standard protocol and treated with sodium bisulfite using Zymo EZ DNA Methylation kit. 
PCR was run with a primer pair (See Supplementary Table 1) flanking a region (873-1192 
bp) upstream from the FosB TSS. TOPO cloning was then performed following the 
manufacturer's instructions (Invitrogen). Minipreps were prepared and sequenced by Sanger 
sequencing (Macrogen).
Locomotor sensitization
Locomotor sensitization was measured per published protocols7 with minor modifications. 
Activity was assessed in the x and y planes for horizontal ambulations in a 75 cm2 chambers 
using Ethovision XT (Noldus). On each day of sensitization, mice were injected with saline 
and analyzed for 10-15 minutes, then immediately injected with cocaine (5 or 10 mg/kg) and 
analyzed for 45-60 min. In some cases, locomotor activity was measured seven days after 
the last cocaine injection after mice were given a challenge injection of cocaine (5 mg/kg). 
Heatmap color-scales were generated by pooling individual pixel values across animals and 
treatments. Each animal's pixel values were computed from raw x- and y-beam break counts 
normalized to that animals total count. The pairwise summation of 4 x and 8 y-beam break 
counts resulted in 32 pixel values for each animal; each value was divisively normalized by 
the total sum of the 12 beam break counts and rounded to the nearest integer. Pixel values 
from all animals in a given plot were then pooled, and the number of unique integers in the 
pool determined the number of colors comprising a scale starting with dark blue, ranging 
through blue, cyan, green, yellow, and red, and ending with dark red. Calculations and 
image generation were performed using MATLAB R2012b (The Mathworks, Natick, MA). 
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Representative images show the locomotor activity of one animal in each group, selected as 
that which displayed total locomotor activity closest to the mean on day 1 of the experiment.
Subthreshold social defeat and social interaction test
This paradigm is used to detect the mechanisms that promote a depression-like phenotype36. 
Male C57BL/6J mice were exposed to a novel CD1 male aggressor for 5 min, 3 times with 
15 min intervals between each exposure. A social interaction test was performed 24 hours 
later. For this test, the subject is placed in an open field arena divided into an interaction 
zone and two opposing corner zones. A social target (novel CD1 mouse) is placed in a metal 
mesh-plastic box in the interaction zone, which allows sensory but not physical interaction. 
Ethovision XT (Noldus) tracking software was used to measure the duration (s) the subject 
mouse spent in the interaction zone with and without the target CD1 present (2.5 mi). Heat 
maps and post-acquisition processing were conducted in MATLAB (Mathworks) according 
to published protocols51. Representative images show the locomotor activity of one animal 
in each group from a single experiment. This experiment was repeated twice with separate 
animal cohorts.
Human postmortem brain tissue
Human postmortem brain tissue was obtained from the Dallas Brain Collection (DBC), 
where tissue is collected from the Dallas Medical Examiner's Office and the UT 
Southwestern Tissue Transplant Program after consent from the next of kin. Tissue was 
analyzed from 9 depressed patients (5 male, 4 female; age 44±7, PMI 15±2) and 18 controls 
(15 male, 3 female; age 51±3; PMI 16±1). The UT Southwestern IRB reviewed and 
approved the collection of this tissue for research use. A direct informant interview was 
carried out for each depression sample at a later date, where information regarding the 
individual's illness was documented; a consensus diagnosis of major depressive disorder was 
made by psychiatrists using DSM-IV criteria. None of the samples included in the study had 
blood toxicology screens positive for drugs of abuse, alcohol, or prescription drugs, 
including antidepressants. NAc dissection, tissue processing, and chromatin preparation 
were performed as reported previously52. qChIP was performed using anti-H3K9me2 
antibody (ab1220, AbCam) previously bound to magnetic beads (Dynabeads M-280, Life 
Technologies). Analysis of relative enrichment was performed using qRT-PCR as described.
Statistics
The appropriate statistical test was determined based on the number of comparisons being 
done. Student's t-tests were used for comparison of two groups, in the analysis of qRTPCR, 
qChIP, and social interaction data. One-way ANOVA was used for analysis of three or more 
experimental groups, with a Bonferroni correction test post-hoc, when appropriate, in the 
analysis of mouse locomotor data. Main and interaction effects were considered significant 
at p < 0.05. Data are expressed as mean ± SEM. The Grubbs test was used when appropriate 
to identify outliers. F tests of variance were conducted on all datasets to ensure that the data 
followed a normal distribution. All experiments were carried out one to three times, and data 
replication was observed in instances of repeated experiments. Experimental sample sizes as 
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indicated in the figure legends were determined gave the reported s.e.m. values that were 
sufficiently low to allow meaningful interpretation of the data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Engineered transcription factors targeting the FosB promoter bidirectionally regulate gene 
expression in NAc neurons via epigenetic manipulation. (a) Locations of FosB-ZFP binding 
relative to the FosB TSS. The location of functional SRF and CREB binding sites are 
shown. CpG: methylation sites analyzed in Fig. 1i. (b) HSV injection into the mouse NAc43 
drives robust transgene expression in neurons. (c) The 6-finger ZFP35 recognizes the FosB 
promoter at approximately 250 bp upstream from the FosB TSS. (d) At 72 hours post-
injection, FosB/ΔFosB mRNA expression in the NAc was significantly induced by HSV-
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FosB-ZFP35-p65 compared to control virus [FosB: t7=2.37, *P=0.049; ΔFosB: t7=3.83, 
*P=0.007; n=4, 5], , with a trend for ΔFosB induction by FosB-ZFP61-p65 
[t7=2.03, τP=0.076; n=4, 5]. Compared to controls, FosB/ΔFosB mRNA in the NAc were 
significantly repressed by HSV-FosB-ZFP35-G9a [FosB: t6=4.84, *P=0.003; ΔFosB: 
t6=3.40, *P=0.015; n=5, 3], -FosB-ZFP61-NFD [FosB t7=2.39, *P=0.048; ΔFosB: 
t7=2.18, τP=0.066; n=4, 5], and FosB-ZFP61-G9a [FosB: t8=2.98, *P=0.017; ΔFosB: 
t8=2.37, *P=0.047; n=5, 5]. HSV-G9a, -p65, -Klf4-ZFP-p65, VEGF-ZFP-G9a and -FosB-
ZFP35-NFD had no effect on FosB/ΔFosB mRNA expression. Student's unpaired t-test 
P>0.05 for all other comparisons (see Supplementary Table 3). (e) Compared to HSV-FosB-
ZFP35-NFD [n=9], NAc injection of HSV-FosB-ZFP35-p65 caused increased FosB/ΔFosB 
protein level [FosB: t13=3.73, *P=0.003; ΔFosB: t13=6.65, *P=0.000; n=6], while HSV-
FosB-ZFP35-G9a had no effect at 72 hours post-injection [FosB: t14=0.137, P=0.8929; 
ΔFosB: t14=1.25, P=0.230; n=8. Representative western blot shown. Complete western blot 
shown in Supplementary Figure 5. (f) NAc injection of HSV-FosB-ZFP35-p65 causes 
enrichment of the activating mark H3K9/14ac at the FosB promoter at –1250 [t8=2.65, 
*P=0.029; n=5, 5] and –250 bp [t8=2.9, *P=0.021; n=5, 5] relative to the TSS compared to 
control HSV, with no change in tissue treated with HSV-FosB-ZFP35-NFD [t10=0.00, 
P=1.00; n=6, 6] or at the cFos promoter [t7=0.217, P=0.834; n=5, 4]. IgG control IP was 
undetectable in >80% of the sample wells by qRT-PCR. (g) NAc injection of HSV-FosB-
ZFP35-G9a caused enrichment of the repressive mark H3K9me2 at the FosB promoter at –
1250 [t26=2.7, *P=0.011; n=14, 14], –500 [t14=2.3, *P=0.041; n=7, 9], and –250 bp 
[t13=2.9, *P=0.031; n=7, 8] relative to the TSS compared to control HSV, with no change in 
tissue treated with HSV-FosB-ZFP35-NFD [–1250: t19=0.45, P=0.658, n=14, 7; –500: 
t8=0.03, P=0.977, n=7, 3; –250: t9=1.51, P=0.167, n=8, 3] or at the cFos promoter [t16=0.42 
P=0.680; n=7, 11]. IgG control IP was undetectable in >80% of the sample wells by qPCR. 
(h) NAc injection of HSV-FosB-ZFP35-G9a caused depletion of the repressive mark 
H3K9me3 [t8=3.3, *P=0.011; n=5, 5] and enrichment of HP1α [t7=2.5, *P=0.039; n=4, 4] 
at the FosB promoter –1250 bp upstream from the TSS compared to control HSV-FosB-
ZFP35-NFD. (i) Bisulfite sequencing analysis performed on three CpG sites located –1141, 
–1101 and –1036 bp upstream of the FosB TSS, in a region that corresponds to the observed 
H3K9me2 and HP1α enrichment (See Fig. 1a). There was no difference in the percentage of 
methylated CpGs in NAc infected with HSV-FosB-ZFP35-G9a [n=19] compared to HSV-
FosB-ZFP35-NFD [n=23]. Each row represents analysis performed on one clone. Data are 
presented as mean ± s.e.m.
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Figure 2. 
HSV-FosB-ZFP35-p65 and -G9a in the NAc specifically regulate FosB/ΔFosB expression. 
(a) Induction of H3K9me2 at the FosB promoter by HSV-FosB-ZFP-G9a in NAc occurs 
relative to the TSS at –1250 bp [t5=2.75, *P=0.040; n=3, 4] and –250 bp [t5=2.69, 
*P=0.043; n=3, 4] without changes in the activating marks H3K9/14ac [–1250: t5=1.49, 
P=0.197; –500: t5=0.50, P=0.636; –250: t5=0.39, P=0.715; n=3, 4] or H3K4me3 [–1250: 
t5=0.37, P=0.728; –500: t5=0.24, P=0.820; –250: t5=0.22, P=0.835; n=3, 4] or the repressive 
mark H3K27me3 [–1250: t5=0.46, P=0.666; –500: t5=0.59, P=0.583; –250: t5=0.23, 
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P=0.831; n=3, 4] as compared to the control (HSV-FosB-ZFP-NFD). (b) cDNA was 
generated from NAc injected with HSV-FosB-ZFP35-p65, -G9a or NFD. qRT-PCR was 
used to measure expression of potential off-target genes (See Supplementary Table 2) in 
samples that show regulation of FosB/ΔFosB by HSV-FosB-ZFP35-p65 [FosB: t7=4.73, 
*P=0.002; ΔFosB: t7=4.83, *P=0.002; n=4, 5] and HSV-FosB-ZFP35-G9a [FosB: t8=2.40, 
*P=0.043; ΔFosB: t8=2.88, *P=0.021; n=5, 5] but not HSV-FosB-ZFP35-G9a [FosB: 
t8=0.38, P=0.715; ΔFosB: t8=0.52, P=0.619; n=5, 5]. Data are normalized to HSV-GFP. 
Student's unpaired t-test P>0.05 for all other comparisons (see Supplementary Table 3). (c) 
HSV-FosB-ZFP35-G9a in the NAc does not cause H3K9me2 enrichment at off-target loci 
as measured by qChIP using primers that flank the off-target binding site [Ptprn2: t4=0.03, 
P=0.97; Pygo1: t5=0.10, P=0.922; Sardh: t4=0.93, P=0.407; Syncrip: t4=0.34, P=0.775; 
Tlr12: t4=1.80, P=0.152; n=3, 3].
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Figure 3. 
Cocaine induction of FosB/ΔFosB protein expression and endogenous transcription factor 
binding is blocked by HSV-FosB-ZFP35-G9a in the NAc. (a) Mice were injected intra-NAc 
with HSV-FosB-ZFP35-NFD or -G9a and treated with repeated cocaine (20 mg/kg) or 
saline. (b) Cocaine induction of FosB/ΔFosB+ cells in the NAc is suppressed by FosB-
ZFP35-G9a [two-way ANOVA: interaction between virus (NFD, G9a) and drug (saline, 
cocaine) (F(1,28)=6.6, *P=0.016, n=8); no main effects of virus (F(1,28)=0.98, P=0.330, 
n=8) or drug (F(1,28)=1.18, P=0.286, n=8) alone]. Cocaine enhances FosB+ cell levels 
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within NFD-infected tissue [t14=2.48, *P=0.027; n=8] but not G9a-infected tissue [t14=1.20, 
P=0.291; n=8]. Among animals receiving cocaine, G9a repressed FosB/ΔFosB+ cells 
[t14=2.25, *P=0.041; n=8]. (c) Representative images from mice infected with HSV-FosB-
ZFP35-NFD in the left hemisphere and HSV-FosB-ZFP35-G9a into the right hemisphere. 
Ac, anterior commissure. (d) Compared to saline, repeated cocaine treatment caused 
enrichment of phospho-CREB(S133) at the FosB promoter in NAc injected with HSV-
FosB-ZFP35-NFD [t17=2.38, *P=0.029; n=9, 11], but not with HSV-FosB-ZFP-G9a 
[t15=0.09, P=0.932; n=8, 9]. (e) No change was observed in total CREB at the FosB 
promoter after cocaine treatment in NAc injected with either virus [NFD: t18=1.55, P=0.138; 
n=9, 11; G9a: t15=1.13, P=0.274; n=8, 9]. (f) Compared to saline, repeated cocaine 
treatment causes enrichment of phospho-SRF(S103) at the FosB promoter in NAc injected 
with HSV-FosB-ZFP35-NFD [t(1, 6)= 2.7, p=0.034; n=4, 4] compared to repeated saline 
with only a modest effect of HSV-FosB-ZFP-G9a in blocking this enrichment [t(1, 8)= 
1.9, τP=0.097; n=5, 5]. (g) NAc injection of HSV-FosB-ZFP-G9a causes enrichment of 
HP1α at the FosB promoter compared to HSV-FosB-ZFP-NFD under cocaine conditions 
[t(1, 7)= 1.24, *P=0.0002, n=4, 5] and a trend under saline treatment conditions [t(1, 8)= 
1.97, τP =0.085; n=4, 5].
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Figure 4. 
Engineered transcription factors bidirectionally modulate cocaine- and stress-evoked 
behaviors. (a) Locomotor activity was assessed during repeated cocaine exposure in mice 
injected intra-NAc with HSV-FosB-ZFP35-G9a [n=7], -p65 [n=9], -NFD [n=9] or control 
virus [n=5 (10mg/kg) or n=10 (5mg/kg)]. (b) Social behavior was measured 24 hours after 
subthreshold social defeat in mice injected with HSV-FosB-ZFP35-G9a or control virus into 
the NAc. (c) At high doses of cocaine (10 mg/kg), locomotor behavior sensitizes over time 
and this effect was blocked by HSV-FosB-ZFP35-G9a in NAc. Repeated measures ANOVA 
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revealed an interaction between day, cocaine, and virus [F(3,18)=4.00, *P=0.024] on 
locomotor behavior. Among cocaine treated mice, there is a main effect of virus 
[F(1,10)=8.81, *P=0.026] and a trend for an interaction between virus and day 
[F(2,8)=3.33, τP=0.077] such that GFP locomotor behavior is enhanced above FosB-ZFP35-
G9a levels by treatment day 6 [t(1,10)=2.61, *P =0.026]. (d) At low doses (5 mg/kg), 
cocaine-induced locomotor behavior sensitizes over time with FosB-ZFP35-p65 in NAc 
[repeated measures: interaction between day, treatment, and virus [F(3,32)=4.71, *P=0.008]. 
Among cocaine treated mice, there is an interaction between virus and day [F(2,15)=7.08, 
*P=0.003] and a trend for a main effect of day among FosB-ZFP35-p65 
[F(1,32)=2.85, τP=0.053] but not GFP cocaine treated animals. Among cocaine-treated 
animals, FosB-ZFP35-p65 enhances locomotor behavior above GFP levels by treatment day 
4 [t17=2.58, *P=0.020] through day 16 [t17=2.92, *P=0.009]. (e) NAc injection of HSV-
FosB-ZFP35-NFD, like controls, did not display cocaine locomotor sensitization to a low 
dose of cocaine. Repeated measures failed to find an interaction among day, treatment, and 
virus [F(1,28)=0.13, P=0.944]. There is no effect of day among cocaine-treated mice 
[F(1,28)=0.86, P=0.471]. HSV-GFP data are the same as in (Fig. 4d). (f) Heat maps show 
representative locomotor data within the chamber for mice over the course of repeated 
cocaine exposure. (g) H3K9me2 is significantly enriched at –1250 bp from the FosB TSS in 
depressed humans [t22=2.19, p=0.040, n=8, 17] compared to levels in control subjects. (h) 
FosB-ZFP35-G9a in the NAc reduced exploration of the open arm in the elevated plus maze, 
compared to control virus [t12=2.36, *P=0.036; n=7]. (i) HSV-FosB-ZFP35-G9a in the NAc 
blocked increased exploration of a novel aggressor mouse after exposure to subthreshold 
social defeat, compared to control virus [t123.1, *P=0.009; n=7] with no effect of HSV-
FosB-ZFP35-NFD [t12=3.2, *P=0.008; n=7]. (j) Representative heatmaps of social 
interaction after a subthreshold defeat stress show a preference for the interaction zone when 
a target mouse is present for mice injected with control virus and HSV-FosB-ZFP35-NFD, 
but not HSV-FosB-ZFP35-G9a.
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